Skip to content

Investigating the Experience of Living With Down Syndrome and Obstructive Sleep Apnea Syndrome (Stage 1)

Positive Airway Pressure for the Treatment of the Obstructive Sleep Apnea Syndrome in Children With Down Syndrome (Stage 1)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04124471
Enrollment
42
Registered
2019-10-11
Start date
2019-08-02
Completion date
2022-08-01
Last updated
2023-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down Syndrome, Obstructive Sleep Apnea

Keywords

Down Syndrome, Obstructive Sleep Apnea

Brief summary

To identify the perceptions, beliefs, and family-relevant outcomes regarding the treatment of obstructive sleep apnea syndrome (OSAS) with positive airway pressure (PAP) in children with Down's Syndrome (DS).

Detailed description

This is a multi-center outpatient study to be performed at two clinical sites: Children's Hospital of Philadelphia and Cincinnati Children's Hospital. Forty Caregivers of children with DS and OSAS treated with PAP and their children will be enrolled. The study comprises one 30-minute open-ended semi-structured interview per caregiver. The duration of the interview is approximate. It will last up to 30 minutes as some families may want to include more details.

Interventions

BEHAVIORALOpen-ended semi-structured interviews

Semi-structured interviews will explore such key constructs as knowledge/belief about OSAS and PAP therapy, routines and resources that promote or limit PAP use, barriers, self-efficacy, and communication and attitudes about PAP. The interviews will be performed with the parent and that they will be audio-recorded.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
University of Pennsylvania
CollaboratorOTHER
Children's Hospital Medical Center, Cincinnati
CollaboratorOTHER
Children's Hospital of Philadelphia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

-- Patients * Children with DS and OSAS treated with PAP for at least 6 months * Children aged between 6 and 17.5 years * English proficiency Inclusion Criteria -- Caregivers * Parent or legal guardian of an eligible patient subject * English proficiency * Must live with the patient subject at least 4 nights of the week

Exclusion criteria

-- Patients * In foster care * Diagnosed with major illness, such as leukemia or severe cyanotic congenital heart disease listed for cardiac transplant as these severe diseases may add confounders

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Completed Interviews Regarding Positive Airway Pressure (PAP) Acceptabilityone dayPAP feasibility will be measured by completion of semi-structured interviews to explore attitudes about PAP therapy in youth with Down Syndrome and Obstructive Sleep Apnea Syndrome.

Countries

United States

Participant flow

Participants by arm

ArmCount
Interview Completion
The number of participants who completed the interview process.
41
Total41

Withdrawals & dropouts

PeriodReasonFG000
Overall Studyscreen failure1

Baseline characteristics

CharacteristicInterview Completion
Age, Customized
Age at screening
12.6 years
STANDARD_DEVIATION 3.8
Ethnicity (NIH/OMB)
All Sites
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
All Sites
Not Hispanic or Latino
41 Participants
Ethnicity (NIH/OMB)
All Sites
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
All Sites
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
All Sites
Asian
2 Participants
Race (NIH/OMB)
All Sites
Black or African American
10 Participants
Race (NIH/OMB)
All Sites
More than one race
0 Participants
Race (NIH/OMB)
All Sites
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
All Sites
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
All Sites
White
29 Participants
Region of Enrollment
United States
41 participants
Sex: Female, Male
All Sites
Female
28 Participants
Sex: Female, Male
All Sites
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 41
other
Total, other adverse events
0 / 41
serious
Total, serious adverse events
0 / 41

Outcome results

Primary

Number of Participants Who Completed Interviews Regarding Positive Airway Pressure (PAP) Acceptability

PAP feasibility will be measured by completion of semi-structured interviews to explore attitudes about PAP therapy in youth with Down Syndrome and Obstructive Sleep Apnea Syndrome.

Time frame: one day

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Interview CompletionNumber of Participants Who Completed Interviews Regarding Positive Airway Pressure (PAP) AcceptabilitySite 1 -- CHOP20 Participants
Interview CompletionNumber of Participants Who Completed Interviews Regarding Positive Airway Pressure (PAP) AcceptabilitySite 2 -- Cincinnati Children's Hospital21 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026